Detalhe da pesquisa
1.
In-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum.
J Proteome Res
; 23(1): 386-396, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113368
2.
Progress in the Management of Pancreatic Neuroendocrine Tumors.
Annu Rev Med
; 73: 213-229, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669433
3.
A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Int J Mol Sci
; 25(5)2024 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38474199
4.
Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy.
Oncologist
; 28(6): 531-541, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036699
5.
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
J Natl Compr Canc Netw
; 21(7): 694-704, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433432
6.
A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.
Cancer
; 128(19): 3523-3530, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895381
7.
T-Cell Subsets as Potential Biomarkers for Hepatobiliary Cancers and Selection of Immunotherapy Regimens as a Treatment Strategy.
J Natl Compr Canc Netw
; 20(2): 203-214, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130506
8.
Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer.
Int J Mol Sci
; 23(14)2022 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887203
9.
Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials.
Expert Opin Emerg Drugs
; 26(2): 103-129, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33734833
10.
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(5): 541-565, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030131
11.
Immunotherapy for pancreatic ductal adenocarcinoma.
J Surg Oncol
; 123(3): 751-759, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33595893
12.
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Lancet Oncol
; 21(4): 508-518, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135080
13.
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
Lancet Oncol
; 21(5): 671-684, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203698
14.
Quantitative Imaging Assessment for Clinical Trials in Oncology.
J Natl Compr Canc Netw
; 17(12): 1505-1511, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805530
15.
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
J Natl Compr Canc Netw
; 17(4): 302-310, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959462
16.
Irinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies.
J Oncol Pharm Pract
; 25(4): 980-986, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562843
17.
Reply to "Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?"
Cancer
; 129(7): 1131-1132, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692955
18.
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.
Invest New Drugs
; 36(4): 683-695, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508247
19.
Opportunities and Challenges for Pancreatic Circulating Tumor Cells.
Gastroenterology
; 151(3): 412-26, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339829
20.
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
J Natl Compr Canc Netw
; 15(5): 563-573, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476736